Long PerspectiveI don’t think we need to work ourselves into a lather. Gains will materialize when revenues and profits take center stage. No speculative news will supersede fundamentals at this point. Given the turnaround initiated by Irwin and the new team, perhaps we should trust his leadership. He has earned it IMO. I have been long and through the wars and try to avoid most of the noise. If you believe in the company actually as an investment and not a trade the current action is opportunity. Irwin did say CANNTRUST has good assets and last time I looked, administrative malpractice did not affect the physical assets or more importantly, the clinical research. These types of assets could be considerable and worth more than all the brick and mortar combined. I say we trust our new team to evaluate and make the right decisions. If you don’t like what’s going on then you all have options.